发明名称 MULTIMODALITY AGENTS FOR TUMOR IMAGING AND THERAPY
摘要 A compound that is a conjugate of an antagonist to an integrin expressed by a tumor cell and at least one of a tumor avid tetrapyrollic photosensitizer, a fluorescent dye, and a radioisotope labeled moiety wherein the radioisotope is 11C, 18F, 64Cu, 124I, 99Tc, 111In or GdIII and its method of use for diagnosing, imaging and/or treating hyperproliferative tissue such as tumors. Preferably the photosensitizer is a tumor avid tetrapyrollic photosensitizer, e.g. a porphyrin, chlorin or bacteriochlorin, e.g. pheophorbides and pyropheophorbides. Such conjugates have extreme tumor avidity and can be used to inhibit or completely destroy the tumor by light absoption. The integrin is usuallyαvβ3,α5β1,αvβ5,α4β1, orα2β1. Preferably, the antagonist is an RGD peptide or another antagonist that may be synthetic such as a 4-{2-(3,4,5,6-tetra-hydropyrimidin-2-ylamino)ethyloxy}-benzoyl]amino-2-(S)-amino-ethyl-sulfonylamino group. Such compounds provide tumor avidity and imaging ability thus permitting selective and clear tumor imaging.
申请公布号 US2011223102(A1) 申请公布日期 2011.09.15
申请号 US20080677381 申请日期 2008.09.11
申请人 HEALTH RESEARCH, INC.;THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 发明人 PANDEY RAVINDRA K.;PANDEY SURESH;GOSWAMI LALIT;OSEROFF ALLAN;DUBEY SHIPRA;SAJJAD MUNAWWAR;PINCUS STEPHANIE
分类号 A61K51/04;A61K31/30;A61K31/409;A61K31/437;A61K31/506;A61K38/12;A61K49/00;A61P35/00;A61P43/00 主分类号 A61K51/04
代理机构 代理人
主权项
地址